Literature DB >> 1691790

Control of ColE1 plasmid replication. Intermediates in the binding of RNA I and RNA II.

J Tomizawa1.   

Abstract

Replication of plasmid ColE1 is regulated by a plasmid-specified small RNA (RNA I). RNA I binds to the precursor (RNA II) of the primer for DNA synthesis and inhibits primer formation. The process of binding of RNA I to RNA II that results in formation of a stably bound complex consists of a series of reactions forming complexes differing in the stability. Formation of a very unstable early intermediate that was previously inferred from the inhibition of stable binding caused by a second RNA I species was firmly established by more extensive studies. This complex is converted to a more stable yet reversible complex that was identified by its RNase sensitivity, which was altered from that of the earlier complex or from that of free RNA I or RNA II. In these complexes, most loops of RNA II interact with their complementary loops of RNA I. The kinetic and structural analyses of the binding process predict formation of a complex interacting at a single pair of complementary loops that precedes formation of these complexes. Thus the process of binding of RNA I to RNA II is seen to consist of a sequence of reactions producing a series of progressively more stable intermediates leading to the final product.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 1691790     DOI: 10.1016/0022-2836(90)90230-j

Source DB:  PubMed          Journal:  J Mol Biol        ISSN: 0022-2836            Impact factor:   5.469


  18 in total

1.  In vitro selection identifies key determinants for loop-loop interactions: RNA aptamers selective for the TAR RNA element of HIV-1.

Authors:  F Ducongé; J J Toulmé
Journal:  RNA       Date:  1999-12       Impact factor: 4.942

2.  Bulged residues promote the progression of a loop-loop interaction to a stable and inhibitory antisense-target RNA complex.

Authors:  F A Kolb; E Westhof; C Ehresmann; B Ehresmann; E G Wagner; P Romby
Journal:  Nucleic Acids Res       Date:  2001-08-01       Impact factor: 16.971

3.  Association of an RNA kissing complex analyzed using 2-aminopurine fluorescence.

Authors:  M Rist; J Marino
Journal:  Nucleic Acids Res       Date:  2001-06-01       Impact factor: 16.971

4.  The effect of loop size in antisense and target RNAs on the efficiency of antisense RNA control.

Authors:  T Hjalt; E G Wagner
Journal:  Nucleic Acids Res       Date:  1992-12-25       Impact factor: 16.971

5.  Sequence-specific artificial ribonucleases. I. Bis-imidazole-containing oligonucleotide conjugates prepared using precursor-based strategy.

Authors:  Natalia G Beloglazova; Martin M Fabani; Marina A Zenkova; Elena V Bichenkova; Nikolai N Polushin; Vladimir V Sil'nikov; Kenneth T Douglas; Valentin V Vlassov
Journal:  Nucleic Acids Res       Date:  2004-07-23       Impact factor: 16.971

6.  Structural specificity conferred by a group I RNA peripheral element.

Authors:  Travis H Johnson; Pilar Tijerina; Amanda B Chadee; Daniel Herschlag; Rick Russell
Journal:  Proc Natl Acad Sci U S A       Date:  2005-07-11       Impact factor: 11.205

7.  Transcription termination within the iron transport-biosynthesis operon of Vibrio anguillarum requires an antisense RNA.

Authors:  Michiel Stork; Manuela Di Lorenzo; Timothy J Welch; Jorge H Crosa
Journal:  J Bacteriol       Date:  2007-03-02       Impact factor: 3.490

Review 8.  Rational vector design for efficient non-viral gene delivery: challenges facing the use of plasmid DNA.

Authors:  Juergen Mairhofer; Reingard Grabherr
Journal:  Mol Biotechnol       Date:  2008-06       Impact factor: 2.695

9.  Interaction between the antisense and target RNAs involved in the regulation of IncB plasmid replication.

Authors:  K R Siemering; J Praszkier; A J Pittard
Journal:  J Bacteriol       Date:  1993-05       Impact factor: 3.490

10.  Use of mchI encoding immunity to the antimicrobial peptide microcin H47 as a plasmid selection marker in attenuated bacterial live vectors.

Authors:  Chee-Mun Fang; Jin Yuan Wang; Magaly Chinchilla; Myron M Levine; William C Blackwelder; James E Galen
Journal:  Infect Immun       Date:  2008-07-28       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.